Skip to main content

RT @RichardPAConway: Yazici et al. RCT of IA Lorecivivint for moderate/severe knee OA. CLK/DYRK inhibitor. No effect se

Nov 14, 2022 8:36 am
Social Author Name
Richard Conway
Tweet Content
Yazici et al. RCT of IA Lorecivivint for moderate/severe knee OA. CLK/DYRK inhibitor. No effect seen. @RheumNow #ACR22 Abstr#1899 https://t.co/XGQrMmNnSR https://t.co/rSJrT6Hms6
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×